雾化器市场规模、份额和成长分析（按类型、模式、应用、最终用途和地区）- 产业预测 2025-2032

预计到 2023 年雾化器市场规模将达到 12.3 亿美元，并从 2024 年的 13.1 亿美元增长到 2032 年的 21 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.1%。

由于慢性呼吸系统疾病盛行率上升、家庭医疗保健需求增加以及人口老化等多种因素，雾化器市场正在经历强劲增长。其中，慢性阻塞性肺病（COPD）在美国死因中排名第四，其主要原因是吸烟、食用加工食品等生活习惯。根据疾病预防控制中心的报告，北美30-70岁成年人的死亡中约有14%与吸烟有关，凸显了呼吸系统疾病与雾化器需求之间的关联。在全球整体，COPD 导致约 323 万人死亡，然而，全球对抗慢性呼吸系统疾病联盟等措施有望加强诊断和治疗，进一步增加雾化器市场的成长潜力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

雾化器市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 喷射
• 网
  • 积极的
  • 被动的
• 超音波

雾化器市场规模（按模式和复合年增长率） (2025-2032)

• 市场概况
• 可携式的
• 桌面

雾化器市场规模（按应用和复合年增长率） (2025-2032)

• 市场概况
• 慢性阻塞性肺病
• 囊肿纤维化
• 气喘
• 其他的

雾化器市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 医院和诊所
• 急诊中心
• 家庭医疗保健

雾化器市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Omron Corporation（Japan）
• Allied Healthcare（United Kingdom）
• Teleflex Incorporated（United States）
• Briggs Healthcare（United States）
• Aerogen（Ireland）
• Medtronic Plc（Ireland）
• GE Healthcare（United States）
• DeVilbiss Healthcare LLC（United States）
• Koninklijke Philips NV（Netherlands）
• Vectura Group Plc.（United Kingdom）
• PARI Respiratory Equipment, Inc.（Germany）
• Beurer GmbH（Germany）
• Covidien plc（Ireland）
• Becton, Dickinson and Company（BD）（United States）
• Rossmax International Ltd.（Taiwan）
• Nulife Global Medical Devices（India）
• BPL Medical Technologies（India）
• Agaro（India）
• Medline Industries, LP（United States）
• Drive DeVilbiss Healthcare（United States）

结论和建议

Nebulizer Market size was valued at USD 1.23 billion in 2023 and is poised to grow from USD 1.31 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032).

The Nebulizer market is experiencing robust growth driven by several factors including the rising prevalence of chronic respiratory diseases, increased demand for home healthcare, and an aging population. Chronic Obstructive Pulmonary Disease (COPD) is particularly concerning, ranking as the fourth leading cause of death in the U.S., largely due to lifestyle factors like tobacco and processed product consumption. The CDC reports that around 14% of deaths in adults aged 30-70 in North America are related to tobacco use, emphasizing the link between respiratory diseases and nebulizer demand. Globally, COPD accounts for approximately 3.23 million deaths, but initiatives like the "Global Alliance against Chronic Respiratory Diseases" are expected to enhance diagnosis and treatment, further boosting the nebulizer market's growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nebulizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nebulizer Market Segments Analysis

Global Nebulizer Market is segmented by Type, Modality, Application, End-use and region. Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on Modality, the market is segmented into Portable and Table-top. Based on Application, the market is segmented into COPD, Cystic Fibrosis, Asthma and Others. Based on End-use, the market is segmented into Hospitals And Clinics, Emergency Centers and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nebulizer Market

The increasing prevalence of respiratory ailments, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, serves as a major driver for the nebulizer market. These health conditions necessitate efficient medication delivery systems to effectively reach the respiratory tract, making nebulizers an essential tool in administering treatments directly to the lungs. As more individuals are diagnosed with these diseases, the demand for nebulizers continues to rise, further boosting the market's growth. This trend highlights the critical role that nebulizers play in enhancing patient care and improving respiratory health outcomes, thereby solidifying their position in the healthcare industry.

Restraints in the Nebulizer Market

The nebulizer market faces significant restraints due to the limitations and inconsistencies in reimbursement policies for nebulizer treatments. This inadequacy in comprehensive coverage can hinder both affordability and accessibility, making it challenging for patients to acquire the necessary nebulizer devices and medications. As a result, many patients encounter obstacles when seeking nebulizer therapy, which ultimately restricts the overall growth potential of the market. Without reliable reimbursement options, the demand for nebulizers may stagnate, impacting manufacturers and healthcare providers alike. Such barriers must be addressed to foster a more supportive environment for both patients and the nebulizer market as a whole.

Market Trends of the Nebulizer Market

The nebulizer market is witnessing a significant trend towards technological innovation, characterized by the increasing adoption of mesh nebulizers that leverage advanced vibrating mesh technology. This shift has resulted in devices that not only deliver medications more efficiently but are also compact and portable, catering to the growing demand for convenience among users. As drug delivery systems evolve, these improvements are enhancing the overall patient experience by minimizing drug loss and optimizing treatment outcomes. Additionally, the rise in respiratory diseases and the focus on personalized healthcare solutions are expected to further drive market growth, making nebulizers a vital component of modern respiratory therapy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Nebulizer Market Size by Type & CAGR (2025-2032)

• Market Overview
• Jet
• Mesh
  • Active
  • Passive
• Ultrasonic

Global Nebulizer Market Size by Modality & CAGR (2025-2032)

• Market Overview
• Portable
• Table-top

Global Nebulizer Market Size by Application & CAGR (2025-2032)

• Market Overview
• COPD
• Cystic Fibrosis
• Asthma
• Others

Global Nebulizer Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals And Clinics
• Emergency Centers
• Home Healthcare

Global Nebulizer Market Size & CAGR (2025-2032)

• North America (Type, Modality, Application, End-use)
  • US
  • Canada
• Europe (Type, Modality, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Modality, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Modality, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Modality, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Omron Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allied Healthcare (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Briggs Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerogen (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DeVilbiss Healthcare LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectura Group Plc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PARI Respiratory Equipment, Inc. (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beurer GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covidien plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nulife Global Medical Devices (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agaro (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, LP (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive DeVilbiss Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations